NCT06568302TerminatedPhase 3
The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial
A Global Open-label Extension Study to Observe the Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial
Source: ClinicalTrials.gov · Last updated 10 Feb 2025
Brief summary (registry, in English)
The purpose of the study is to evaluate the efficacy, safety, tolerability and pharmacokinetic (PK) profile of prophylactic SerpinPC in participants with hemophilia
- Status (registry)
- Terminated
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 15 (actual)
- First submitted
- 21 Aug 2024
- Start date
- 11 Jul 2024
- Primary completion date
- 29 Jan 2025
- Lead sponsor
- ApcinteX Ltd
- Diseases
- Haemophilia
- NCT number
- NCT06568302
- EudraCT number
- 2023-509965-19
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous deep vein thrombosis and pulmonary embolism, myocardial infarction, or embolic stroke
- Treatment with anticoagulant or antiplatelet drugs
Other illness
- Any other significant conditions or comorbidities that, in the opinion of the investigator, would make the subject unsuitable for enrolment or could interfere with participation in or completion of the study
Other
- Participation in another interventional clinical trial, except for SerpinPC trials
Who the study is looking for
- Male participants greater than or equal to (>=) 12 and less than or equal to (<=) 65 years of age at the time of informed consent
- Completed participation in a sponsored SerpinPC hemophilia clinical trial and, in the opinion of the investigator, was compliant with the study including compliance with diary entries.
- Capable of providing written informed consent (adolescent assent and parent/guardian consent when appropriate) for participation
Age in the registry: 12 years to 65 years · Sex: Male · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ARENSIA Exploratory Medicine LLC Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| Institute of Oncology, ARENSIA Exploratory Medicine Coordinator of this site? Confirm its status | Chisinau | Moldova | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.